Pharma Group expects new pharmaceutical law to open up potential

Pharma Group expects new pharmaceutical law to open up potential

Appreciative of the potential of Vietnam's pharma sector Darrell Oh, Pharma Group chairman, spoke with VIR's Nguyen Huong about some of the outstanding development and innovation in the industry.
A more conducive environment needed for investors

A more conducive environment needed for investors

Last year marked Pharma Group’s 25-year journey of partnership in Vietnam. That year was even more significant for healthcare as we have witnessed several key laws issued with great improvements, notably the Law on Bidding and the Law on Medical Examination and Treatment.
Opportunities abound for innovative pharma industry

Opportunities abound for innovative pharma industry

Countries around the world are hoping to entice investment for their innovative pharmaceutical industries in order to bring socioeconomic benefits towards sustainable development strategies.
Fostering pharma-healthcare growth and the spillover effects

Fostering pharma-healthcare growth and the spillover effects

Vietnam’s pharma and healthcare sector is entering a new stage of development, requiring the adoption of innovative approaches and clearly defined policy priorities to achieve long-term goals.
Pharma groups redouble patient-centric efforts

Pharma groups redouble patient-centric efforts

Driven by 2020’s highlights, international pharma giants are planning to deliver more vital medicines and vaccines to Vietnam in 2021 to tap into local demands and enable the country to weather future crises.
Vietnam urged to unlock potential for world-class healthcare 

Vietnam urged to unlock potential for world-class healthcare 

KPMG Vietnam and Pharma Group organised a dialogue to discuss the potential and challenges of Vietnam in unlocking world-class healthcare.
EU pharmaceuticals find appetite with trade deal

EU pharmaceuticals find appetite with trade deal

European Union investment in Vietnam’s lucrative pharmaceutical industry is expected to surge on the back of the EU-Vietnam Free Trade Agreement. EuroCham’s Pharma Group director Geraldine Dufresne gives a deep analysis into how the landmark deal can change the EU investment picture in the industry.